🔎 Trials Near Me

Home › NCT06499740

Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact

Recruiting

Who can join

Ages 10 and older · All sexes

Full eligibility criteria
Adolescent Inclusion Criteria:

* adolescent between the ages of 10 and 18 years old
* speaks fluent English
* current or recent suicide risk

Adolescent Exclusion Criteria:

* high suicide risk (in need of immediate crisis stabilization services such as inpatient medical or psychiatric hospitalization)
* does not speak fluent English
* does not have a primary care provider

Caregiver Inclusion Criteria:

* has a child who meets inclusion criteria
* Age 18 years or older

Caregiver Exclusion Criteria:

* does not have a child who meets inclusion criteria
* does not speak English

Provider Inclusion Criteria:

* Age 18 years or older
* works in primary care/outpatient healthcare setting

About the study

Suicide is a leading cause of death among adolescents in the United States and improving access to high quality just-in-time suicide interventions to reduce risk has important public health implications. Integrating such interventions into routinely accessed settings, such as pediatric primary care, holds promise; however, many clinicians in these settings fail to adequately screen or intervene in youth suicidal thoughts and behaviors, representing a key barrier to reducing suicide. The proposed study is a pre-post quasi-experimental pilot feasibility and preliminary efficacy trial of a suicide prevention intervention informed by evidence based interventions including the SAFETY-Acute suicide prevention intervention implemented in 3 pediatric primary care clinics.

What is being tested

Sponsor: University of Washington · Participants: 48 · Started: May 4, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT06499740

Locations in the U.S.

WashingtonNorthwest Pediatrics, Centralia
Richmond Pediatrics, Mountlake Terrace
Olympia Pediatrics, Olympia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.